Cardiac inflammation, an intricate condition involving the inflammation of the heart tissues, emerges as a pivotal factor in various cardiovascular ailments. This inflammatory response can arise from diverse triggers, including infections, autoimmune disorders, or underlying health issues. The consequences of cardiac inflammation are profound, potentially impairing the heart's ability to pump blood efficiently. Notable manifestations such as myocarditis and pericarditis underscore the significance of timely intervention to avert the risk of heart failure. Researchers and healthcare experts are actively delving into the complex mechanisms of cardiac inflammation, aiming to develop precise interventions and preventative strategies. Comprehensive comprehension and effective management of cardiac inflammation stand as imperative measures in advancing cardiovascular health and alleviating the impact of associated diseases on individuals globally.
Title : New mechanisms and innovative therapeutics for pulmonary hypertension
Yong Xiao Wang, Albany Medical Center, United States
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : CARDIAC TROPONIN AND HOMOCYSTEINE LEVELS IN HEMODIALYSIS PATIENTS: ASSOCIATION WITH DIALYSIS VINTAGE AND CARDIOVASCULAR COMORBIDITY
Sofra Maria, Aretaieion University Hospital, Greece
Title : New recommendations for the prevention of sudden cardiac death in athletes and recreational sports
Sekib Sokolovic, ASA Hospital Sarajevo, Bosnia and Herzegowina
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation